January 11-14, 2027 | San Francisco
2027 Participating Companies
Delphian Therapeutics is a clinical-stage company targeting novel, multi-modal mechanisms to treat large pain and neurological disorders, starting with migraine, one of the world’s largest and most poorly-managed diseases.